Passa al contenuto
Merck
Tutte le immagini(3)

Key Documents

F6129

Sigma-Aldrich

Iron(III) citrate

technical grade

Sinonimo/i:

Ferric citrate, Iron(III) citrate, Iron(III) citrate hydrate

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Formula empirica (notazione di Hill):
C6H5FeO7
Numero CAS:
Peso molecolare:
244.94
Numero CE:
Numero MDL:
Codice UNSPSC:
12352302
ID PubChem:
NACRES:
NA.23

Grado

technical grade

Livello qualitativo

Forma fisica

powder

Composizione

Fe, 16.5-18.5%

tecniche

cell culture | mammalian: suitable

applicazioni

battery manufacturing

Stringa SMILE

OC12CC(=O)O[Fe](OC(=O)C1)OC2=O

InChI

1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3
NPFOYSMITVOQOS-UHFFFAOYSA-K

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

Iron(III) citrate technical grade is a brown to dark orangepowder. It is soluble in water, but insoluble in most organics includingalcohols. The powder is sensitive to light; like many iron carboxylates, bluelight photo-reduces iron(III) citrate, forming the Fe2+ ion andconcomitantly oxidizing the carboxyl group to yield carbon dioxide. Iron(III)citrate thermally decomposes to α-Fe2O3 at 460 °C.

Applicazioni

Iron(III) citrate is a synthetic precursor for iron-containing compounds. It is commonly used to prepare Fe3O4 nanoparticles or Fe3O4-nanocomposites by hydrothermal methods and Fe2O3 materials by thermal decomposition and sol-gel processing. Iron(III) citrate is well-suited to sol-gel processing because of its high solubility in water and low solubility inorganic phases. Consequently, iron(III) citrate is an important precursor in the synthesis of iron-doped and iron-containing metal oxides studied for lithium-ion battery cathodes.

It can also be used in the degradation of tetracycline for the treatment of polluted water.

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 2

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

Eyeshields, Gloves, type N95 (US)


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

P Senthil Kumar et al.
ACS omega, 3(3), 3036-3044 (2018-07-20)
Pristine trivanadate (LiV3O8) and doped lithium trivanadate (LiV3-x M x O8, M = Zn/Co/Fe/Sn/Ti/Zr/Nb/Mo, x = 0.01/0.05/0.1 M) compounds were prepared by a simple reflux method in the presence of the polymer, Pluronic P123, as the chelating agent. For comparison
Jianguo Guan et al.
Chemical communications (Cambridge, England), 46(35), 6605-6607 (2010-08-18)
We present a simple and effective heterogeneous contraction method to fabricate hollow spheres with controllable interior structures (ranging from solid, simple hollow to core-in-hollow-wall, double-wall hollow and core-in-double-hollow-wall spheres) by a non-equilibrium heat-treatment process of gel precursors with a high
Petra Vukosav et al.
Analytica chimica acta, 745, 85-91 (2012-09-04)
A detailed study of iron (III)-citrate speciation in aqueous solution (θ=25°C, I(c)=0.7 mol L(-1)) was carried out by voltammetric and UV-vis spectrophotometric measurements and the obtained data were used for reconciled characterization of iron (III)-citrate complexes. Four different redox processes
Marvin Sinsakul et al.
Nephron. Clinical practice, 121(1-2), c25-c29 (2012-10-19)
A phase II open-label study was conducted in hemodialysis patients evaluating the short-term safety, tolerability, and iron absorption with ferric citrate when used as a phosphate binder. Enrollment occurred in two periods. Period 1 recruited patients taking 6-15 pills/day of
Hiroaki Ito et al.
The journal of physical chemistry. A, 115(21), 5371-5379 (2011-05-13)
The kinetics of ligand exchange between ferric citrate and desferrioxamine B (DFB) was investigated at pH 8.0 and high citrate/Fe molar ratios (500-5000) with particular attention given to understanding the precise mechanism of ligand exchange. Ferric citrate complexes present in

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.